ABVC BioPharma Ownership 2024 | Who Owns ABVC BioPharma Now?

Overview RevenueFinancials Chart

Institutional Ownership

1.78%

Insider Ownership

23.63%

Retail Ownership

74.59%

Institutional Holders

8.00

ABVC BioPharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-129	-100.00%	-	Sep 30, 2023
NORTHERN TRUST CORP	-	-	-	-18,421	-100.00%	-	Sep 30, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-22,101	-100.00%	-	Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-139,282	-100.00%	-	Sep 30, 2023
BLACKROCK INC.	-	-	-	-5,814	-100.00%	-	Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-13,879	-100.00%	-	Sep 30, 2023
SPOTLIGHT ASSET GROUP, INC.	-	-	-	-1,000	-100.00%	-	Sep 30, 2023

ABVC BioPharma's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-129	-100.00%	-	Sep 30, 2023
NORTHERN TRUST CORP	-	-	-	-18,421	-100.00%	-	Sep 30, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-22,101	-100.00%	-	Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-139,282	-100.00%	-	Sep 30, 2023
BLACKROCK INC.	-	-	-	-5,814	-100.00%	-	Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-13,879	-100.00%	-	Sep 30, 2023
SPOTLIGHT ASSET GROUP, INC.	-	-	-	-1,000	-100.00%	-	Sep 30, 2023

The largest ABVC BioPharma shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of ABVC BioPharma (ABVC), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-129	-100.00%	-	Sep 30, 2023
SPOTLIGHT ASSET GROUP, INC.	-	-	-	-1,000	-100.00%	-	Sep 30, 2023
BLACKROCK INC.	-	-	-	-5,814	-100.00%	-	Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-13,879	-100.00%	-	Sep 30, 2023
NORTHERN TRUST CORP	-	-	-	-18,421	-100.00%	-	Sep 30, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-22,101	-100.00%	-	Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-139,282	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, ABVC BioPharma's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.13K stocks of ABVC, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-139,282	-100.00%	-	Sep 30, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-22,101	-100.00%	-	Sep 30, 2023
NORTHERN TRUST CORP	-	-	-	-18,421	-100.00%	-	Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-13,879	-100.00%	-	Sep 30, 2023
BLACKROCK INC.	-	-	-	-5,814	-100.00%	-	Sep 30, 2023
SPOTLIGHT ASSET GROUP, INC.	-	-	-	-1,000	-100.00%	-	Sep 30, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-129	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, ABVC BioPharma's biggest institutional seller is GEODE CAPITAL MANAGEMENT, LLC. The company sold -0.14M shares of ABVC, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-139,282	-100.00%	-	Sep 30, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-22,101	-100.00%	-	Sep 30, 2023
NORTHERN TRUST CORP	-	-	-	-18,421	-100.00%	-	Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-13,879	-100.00%	-	Sep 30, 2023
BLACKROCK INC.	-	-	-	-5,814	-100.00%	-	Sep 30, 2023
SPOTLIGHT ASSET GROUP, INC.	-	-	-	-1,000	-100.00%	-	Sep 30, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-129	-100.00%	-	Sep 30, 2023

ABVC BioPharma's largest sold out institutional shareholder by shares sold is GEODE CAPITAL MANAGEMENT, LLC, sold -0.14M shares, valued at -, as of undefined.

ABVC BioPharma Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	387,513	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	137,699	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	54,494	36,173	197.44%	Dec 31, 2023
iSHARES TRUST	0.00%	11,876	-	-	Feb 29, 2024
EQ ADVISORS TRUST	0.00%	751	-	-	Dec 31, 2023

ABVC BioPharma's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 387.51K shares, compromising 0.00% of its total assets.

ABVC BioPharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 23	8	-
31 Mar, 23	8	-
31 Dec, 22	8	-
30 Sep, 22	8	60.00%
30 Jun, 22	5	25.00%
31 Mar, 22	4	-20.00%
31 Dec, 21	5	-37.50%
30 Sep, 21	8	-

As of 30 Jun 23, 8 institutions are holding ABVC BioPharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 23	588,139	-9.13%
31 Mar, 23	647,212	9.12%
31 Dec, 22	593,122	-4.64%
30 Sep, 22	621,973	-60.20%
30 Jun, 22	1,562,841	265.33%
31 Mar, 22	427,791	-6.81%
31 Dec, 21	459,042	117.73%
30 Sep, 21	210,827	-

ABVC BioPharma (ABVC) has 588.14K shares outstanding as of 30 Jun 23, down -9.13% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 23	1.78%	46.44%
31 Mar, 23	1.96%	55.77%
31 Dec, 22	1.87%	51.38%
30 Sep, 22	1.91%	7.66%
30 Jun, 22	4.99%	240.34%
31 Mar, 22	1.44%	42.93%
31 Dec, 21	1.83%	297.88%
30 Sep, 21	0.78%	-

As of 30 Jun 23, ABVC BioPharma is held by 1.78% institutional shareholders, representing a 46.44% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 23	3	-40.00%
31 Mar, 23	5	-
31 Dec, 22	5	-16.67%
30 Sep, 22	6	100.00%
30 Jun, 22	3	200.00%
31 Mar, 22	1	-75.00%
31 Dec, 21	4	-50.00%
30 Sep, 21	8	-

3 institutional shareholders have increased their position in ABVC stock as of 30 Jun 23 compared to 5 in the previous quarter (a -40.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 23	2	100.00%
31 Mar, 23	1	-50.00%
31 Dec, 22	2	100.00%
30 Sep, 22	1	-
30 Jun, 22	-	-100.00%
31 Mar, 22	2	-
31 Dec, 21	-	-
30 Sep, 21	-	-

2 institutional shareholders have reduced their position in ABVC stock as of 30 Jun 23 compared to 1 in the previous quarter (a 100.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 23	8	-	588,139	-9.13%	1.78%	46.44%	3	-40.00%	2	100.00%
31 Mar, 23	8	-	647,212	9.12%	1.96%	55.77%	5	-	1	-50.00%
31 Dec, 22	8	-	593,122	-4.64%	1.87%	51.38%	5	-16.67%	2	100.00%
30 Sep, 22	8	60.00%	621,973	-60.20%	1.91%	7.66%	6	100.00%	1	-
30 Jun, 22	5	25.00%	1,562,841	265.33%	4.99%	240.34%	3	200.00%	-	-100.00%
31 Mar, 22	4	-20.00%	427,791	-6.81%	1.44%	42.93%	1	-75.00%	2	-
31 Dec, 21	5	-37.50%	459,042	117.73%	1.83%	297.88%	4	-50.00%	-	-
30 Sep, 21	8	-	210,827	-	0.78%	-	8	-	-	-

ABVC BioPharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Buy/Sell	Shares	Price	Value	Shares Held
Mar 31, 2022	An Chihliang	officer	Chief Financial Officer	Sell	-	-	-	13,334
Dec 10, 2021	Odaira Yoshinobu	director	-	Sell	-	-	-	163,702
Nov 05, 2021	King Chi-Hsin Richard	officer	Chief Scientific Officer	Sell	-	-	-	869
Nov 05, 2021	Chou Yen-Hsin	director	-	Sell	-	-	-	5,679
Nov 05, 2021	Doong Howard	officer	Chief Executive Officer	Sell	-	-	-	18,404
Oct 26, 2021	Jiang Tsang Ming	director	-	Sell	-	-	-	6,067
Sep 08, 2015	Lazar Shulamit	director, 10 percent owner, officer	President,Secretary,Treasurer	Sell	-	-	-	60,000,000

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 12, 2022	Jiang Shuling	director, 10 percent owner			Buy	-	-	-	7,908,805
Mar 31, 2022	An Chihliang	officer	Chief Financial Officer		Sell	-	-	-	13,334
Dec 10, 2021	Sakamoto Norimi	director			Buy	-	-	-	-
Dec 10, 2021	Odaira Yoshinobu	director	-		Sell	-	-	-	163,702
Nov 15, 2021	Jiang Tsung Shann	director, officer	CSO and Director		Buy	-	-	-	12,103,971
Nov 15, 2021	Miao Shin-Yu	director	-		Buy	-	-	-	67,378
Nov 15, 2021	Tseng Shih-Chen	director			Buy	-	-	-	-
Nov 15, 2021	Jiang Eugene	director, officer	Chairman of the Board & CBO		Buy	-	-	-	732,716
Nov 15, 2021	Jiang Chang-Jen	director	-		Buy	-	-	-	5,949
Nov 05, 2021	King Chi-Hsin Richard	officer	Chief Scientific Officer		Sell	-	-	-	869
Nov 05, 2021	Chou Yen-Hsin	director	-		Sell	-	-	-	5,679
Nov 05, 2021	Doong Howard	officer	Chief Executive Officer		Sell	-	-	-	18,404
Oct 26, 2021	Jiang Tsang Ming	director	-		Sell	-	-	-	6,067
Sep 08, 2015	Lazar Shulamit	director, 10 percent owner, officer	President,Secretary,Treasurer		Sell	-	-	-	60,000,000
Jan 27, 2012	Stolz Kevin Patrick	officer	VP & Controller	A-Award	Buy	6,250	-	-	6,250
May 25, 2011	Krotine Frank Thomas	officer	COO	A-Award	Buy	300,000	$0.20	$60.00K	300,000
May 11, 2011	Stolz Kevin Patrick	officer	CFO & Controller	A-Award	Buy	50,000	$0.20	$10.00K	50,000
May 11, 2011	IANNOTTI DANIEL V	officer	VP, General Counsel & Secretar	A-Award	Buy	300,000	$0.20	$60.00K	300,000
May 11, 2011	Crockett Robert G	officer	Chief Executive Officer	A-Award	Buy	1,800,000	$0.20	$360.00K	1,800,000
May 11, 2011	Ramsey Sally Judith	director, officer	VP New Product Development	A-Award	Buy	2,100,000	$0.20	$420.00K	2,100,000

The last insider sell of ABVC BioPharma's stock was made by An Chihliang on Mar 31 2022, selling - shares at - per share (valued at -).

ABVC BioPharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	-	6	-
Q3 2015	-	1	-
Q1 2012	1	1	100.00%
Q3 2011	-	3	-
Q2 2011	5	1	500.00%
Q3 2010	1	1	100.00%
Q2 2010	1	-	-
Q1 2010	3	-	-
Q4 2009	4	-	-
Q3 2009	5	10	50.00%
Q2 2009	7	2	350.00%
Q1 2009	17	2	850.00%
Q4 2008	3	1	300.00%
Q3 2008	5	1	500.00%
Q2 2008	5	-	-
Q1 2008	-	5	-
Q3 2007	1	5	20.00%
Q2 2007	-	-	-

0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by ABVC BioPharma's insiders, as of Q2 2022.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	-	-	-
Q3 2015	-	-	-
Q1 2012	-	-	-
Q3 2011	-	-	-
Q2 2011	-	-	-
Q3 2010	-	-	-
Q2 2010	1	-	-
Q1 2010	2	-	-
Q4 2009	4	-	-
Q3 2009	2	-	-
Q2 2009	7	-	-
Q1 2009	16	2	800.00%
Q4 2008	-	-	-
Q3 2008	4	1	400.00%
Q2 2008	-	-	-
Q1 2008	-	-	-
Q3 2007	1	-	-
Q2 2007	-	-	-

As of Q2 2022, Insider owners conducted 0 open market buy trades and 0 open market sell trades of ABVC BioPharma's stocks.

ABVC BioPharma Peer Ownership

Ticker	Company
ANEB	Anebulo Pharmaceuticals, Inc.
VRAX	Virax Biolabs Group Limited
QNRX	Quoin Pharmaceuticals, Ltd.
ALRN	Aileron Therapeutics, Inc.
SABS	SAB Biotherapeutics, Inc.
MGTA	Dianthus Therapeutics, Inc.
INDP	Indaptus Therapeutics, Inc.
ARDS	Aridis Pharmaceuticals, Inc.
NTRB	Nutriband Inc.
LGVN	Longeveron Inc.
RNXT	RenovoRx, Inc.
ELDN	Eledon Pharmaceuticals, Inc.
KTTA	Pasithea Therapeutics Corp.
APTX	Aptinyx Inc.
MNPR	Monopar Therapeutics Inc.
ADTX	Aditxt, Inc.
EVLO	Evelo Biosciences, Inc.
AKTX	Akari Therapeutics, Plc
FBRX	Forte Biosciences, Inc.
ACST	Acasti Pharma Inc.

ABVC Ownership FAQ

Who Owns ABVC BioPharma?

ABVC BioPharma is owned by institutional shareholders (1.78%), insiders (23.63%), and public (74.59%). The largest institutional shareholder of ABVC BioPharma is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of ABVC BioPharma?

ABVC BioPharma's major institutional shareholders are WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, TWO SIGMA INVESTMENTS, LP, GEODE CAPITAL MANAGEMENT, LLC, and BLACKROCK INC.. The top five shareholders own together 0% of the company's share outstanding.

How many ABVC BioPharma shareholders are there?

As of Jun 2023, there are 8 institutional shareholders of ABVC BioPharma.

What percentage of ABVC BioPharma is owned by WELLS FARGO & COMPANY/MN?

WELLS FARGO & COMPANY/MN owns 0 shares of ABVC BioPharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).

What percentage of ABVC BioPharma is owned by NORTHERN TRUST CORP?

As of Sep 2023, NORTHERN TRUST CORP holds 0 shares of ABVC BioPharma (ABVC), compromising 0% of the company, valued at $0.

What percentage of ABVC BioPharma is owned by TWO SIGMA INVESTMENTS, LP?

TWO SIGMA INVESTMENTS, LP is the third largest holder of ABVC BioPharma. The company owns 0 of the company's shares outstanding (worth $0).